Technology
Partnered Programs
News
- Flash Therapeutics installe sa nouvelle plateforme de bioproduction à Toulouse
- Upcoming 2021 ESGCT virtual event
- Upcoming 2021 ASGCT virtual event
- Vectalys receives the Seal of Excellence from the European Commission
- Product launch : LentiFlash
- Bioproduction des immunothérapies en France
- Vectalys will attend the AACR Annual Meeting 2016
- Upcoming ESGCT 2017 in Berlin
- Launch of our brand new website
- Launch of FlashCell
- ASGCT 2017 in Washington, DC
- Vectalys will attend the ASGCT in Washington
- Fundraising : Vectalys raises 0,9M€
- Upcoming CRISPR congress Europe in Berlin
- Poster CRISPR congress Berlin 2016
- Lentifactory: Horizon 2020 SME Instrument - phase I
- AACR Annual Meeting 2017
- Flash Therapeutics establishes its new biomanufacturing platform in Toulouse
- Flash Therapeutics change de dimension pour devenir un leader de la bioproduction des technologies lentivirales à ADN et ARN
- Flash Therapeutics scales up, becoming a leader in the bioproduction of DNA and RNA lentiviral technologies
- Flash Therapeutics et la stratégie vaccinale française
- Upcoming 2020 Cell & Gene Therapy virtual event.
- Upcoming 2019 ESGCT meeting in Barcelona
- Press Release - Flash Therapeutics IRIS project
- Going to BIO 2019 in Philadelphia ?
- 4th Annual Advances in Immuno-Oncology UK Congress
- Upcoming ASGCT 2019 in Washington, D.C.
- Best wishes & happy new year 2019
- GMP lentiviral particle manufacturing facilities to produce gene & cell therapy drugs
- Upcoming ESGCT 2018 in Lausanne – Switzerland
- "A NEW PARADIGM IN DRUG DEVELOPMENT"
- Flash Therapeutics in the press
- Meet us in Boston at BIO USA 2018
- Press release Flash Therapeutics (EN)
- ASGCT 2018: MEET US IN CHICAGO!
- Communiqué de presse Flash Therapeutics (FR)
- ASGCT 2022 in Washington D.C
- LentiFlash® used by the Karolinska Institute to correct HGPS mutation
- ITD Congress 2022 : Meet us
- Vaccination-based immunotherapy mounts T cell responses that reduces liver and lung fibrosis in mice
- Advanced Therapies Congress 2023
- Innovative Biologics & CMC Challenges
General pages